A new oxolane from Enterobacter cloacae.

Area of Science:

• Microbiology
• Natural Product Chemistry
• Pharmacology

Background:

• Enterobacter cloacae is a Gram-negative proteobacterium known for causing diverse and severe infections.
• The emergence of antibiotic resistance necessitates the discovery of novel antimicrobial agents.
• Natural products from microbial sources are a rich resource for drug discovery.

Purpose of the Study:

• To isolate and characterize secondary metabolites from Enterobacter cloacae.
• To identify novel compounds with potential therapeutic applications.
• To evaluate the cytotoxicity of isolated compounds.

Main Methods:

• Fermentation of Enterobacter cloacae.
• Isolation and purification using chromatographic techniques (e.g., column chromatography, HPLC).
• Structure elucidation via spectroscopic methods (e.g., NMR, Mass Spectrometry).
• Cytotoxicity assays.

Main Results:

• One new oxolane compound, designated Rimboxo (1), was identified.
• Three known compounds, Maculosine (2), phenylacetic acid (3), and methyl myristate (4), were also isolated.
• The isolated compounds were characterized using comprehensive spectroscopic and chromatographic analyses.
• Preliminary cytotoxicity evaluations were performed on the isolated compounds.

Conclusions:

• The study successfully identified and characterized a novel oxolane compound, Rimboxo, from Enterobacter cloacae.
• The isolation of known compounds provides a chemical profile of the E. cloacae fermentation.
• Further investigation into the biological activities, particularly cytotoxicity, of these compounds is warranted.